WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008094939) USE OF CHROMIUM HISTIDINATE FOR TREATMENT OF CARDIOMETABOLIC DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/094939    International Application No.:    PCT/US2008/052352
Publication Date: 07.08.2008 International Filing Date: 29.01.2008
IPC:
A61K 31/415 (2006.01), A61P 3/06 (2006.01)
Applicants: NUTRITION 21, INC. [US/US]; 4 Manhattanville Road, Suite 202, Purchase, NY 10577 (US) (For All Designated States Except US).
JUTURU, Vijaya [IN/US]; (US) (For US Only).
KOMOROWSKI, James [US/US]; (US) (For US Only)
Inventors: JUTURU, Vijaya; (US).
KOMOROWSKI, James; (US)
Agent: HART, Daniel; Knobbe Hartens Olson & Bear, Llp, 2040 Main Street, Fourteenth Floor, Irvine, CA 92614 (US)
Priority Data:
60/887,561 31.01.2007 US
Title (EN) USE OF CHROMIUM HISTIDINATE FOR TREATMENT OF CARDIOMETABOLIC DISORDERS
(FR) UTILISATION D'HISTIDINATE DE CHROME POUR LE TRAITEMENT DE TROUBLES CARDIOMETABOLIQUES
Abstract: front page image
(EN)Provided herein are methods for treating, preventing, and improving conditions associated with cardiometabolic syndrome, by identifying a subject in need of treatment, prevention, or improvement of a condition associated with cardiometabolic syndrome, and providing a therapeutically effective amount of a composition comprising chromium and histidine, chromium histidinate complexes, or combinations thereof, to the individual.
(FR)L'invention concerne des procédés de traitement, de prévention et d'amélioration de conditions associées à un syndrome cardiométabolique, en identifiant un sujet nécessitant le traitement, la prévention ou l'amélioration d'une condition associée à un syndrome cardiométabolique et en administrant à l'individu une quantité thérapeutiquement efficace d'une composition contenant du chrome et de l'histidine, des complexes d'histidinate de chrome, ou leurs combinaisons.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)